OraSure Technologies, Inc. - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
OSUR Nasdaq 2835 http://www.orasure.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for OraSure Technologies, Inc.

Aphria (APHA) Looks Good: Stock Adds 6% in Session - Jan 14th, 2021 1:34 pm
OraSure Technologies Announces 2021 Annual Meeting Date - Jan 8th, 2021 11:00 am
OraSure Technologies to Present at the 39th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2021 11:00 am
OraSure’s OMNIgene®·ORAL Device Included in EUA Amendment Granted to 3B BlackBio Biotech India for SARS-CoV-2 Test - Dec 23rd, 2020 11:00 am
OraSure Technologies Provides Update on Its Emergency Use Authorization Application for Its Lab-based Oral Fluid SARS-CoV-2 Antibody Test - Dec 21st, 2020 9:01 pm
OraSure Technologies to Present at the 2020 Evercore ISI HealthCONx Conference - Nov 30th, 2020 12:00 pm
OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Closing Bell - Nov 30th, 2020 12:00 pm
OraSure Technologies to Present at the Stephens Annual Investment Conference 2020 - Nov 12th, 2020 12:00 pm
Stock Upgrades: Orasure Technologies Shows Rising Relative Strength - Nov 9th, 2020 8:52 pm
Clinical Reference Laboratory to Market Most Cost-Effective, Gold-Standard Self-Collected COVID-19 Saliva Test Directly to Consumers - Nov 9th, 2020 1:02 pm
OraSure Technologies, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Nov 6th, 2020 1:59 pm
OraSure Technologies (OSUR) Beats Q3 Earnings and Revenue Estimates - Nov 4th, 2020 11:05 pm
OraSure Technologies, Inc. Announces Third Quarter 2020 Financial Results and Provides Update on COVID-19 Developments - Nov 4th, 2020 9:01 pm
OraSure Technologies, Inc. to Host Earnings Call - Nov 4th, 2020 8:15 pm
OraSure’s DNA Genotek Subsidiary Receives FDA Emergency Use Authorization for its ORAcollect®·RNA Saliva Collection Device for SARS CoV-2 - Nov 3rd, 2020 12:00 pm
Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for - Oct 28th, 2020 4:32 pm
OraSure Technologies to Hold 2020 Third Quarter Earnings Conference Call  Wednesday, November 4, 2020, 5:00 p.m. ET - Oct 21st, 2020 10:00 am
Company News for Oct 20, 2020 - Oct 20th, 2020 2:17 pm
Why OraSure Technologies Stock Is Soaring Today - Oct 19th, 2020 3:44 pm
Return On Capital Employed Overview: OraSure Technologies - Oct 19th, 2020 2:28 pm